NeuBase Therapeutics Inc
(NAS:NBSE)
$
0.378
-0.012499 (-3.2%)
Market Cap: 1.42 Mil
Enterprise Value: -5.82 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 20/100 NeuBase Therapeutics Inc Tribe Public's Presentation and Q&A Webinar Event Transcript
Oct 28, 2020 / 03:30PM GMT
Release Date Price:
$167.4
(-2.90%)
John Heerdink
Jr, Tribe Public, LLC - Moderator
Presentation and Q&A Webinar Event
Oct 28, 2020 / 03:30PM GMT
=====================
Corporate Participants
=====================
* Dietrich Stephan
NeuBase Therapeutics, Inc. - CEO and Founder
=====================
Conference Call Participants
=====================
* John Heerdink, Jr
Tribe Public, LLC - Moderator
=====================
-
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot